
Generate Biomedicinesrevenue & funding
Data Science and Machine Learning PlatformsCambridge, MassachusettsFounded 2018CEO Michael Nally
Public companyGenerate Biomedicines is a biotechnology company founded in 2018 and headquartered in Cambridge, Massachusetts. It specializes in using machine learning and biological engineering to create biomedicines.
Generate Biomedicines revenue
Generate Biomedicines' annual revenue was $31.9M in December 2025 (SEC filing). That is up 56% from $20.5M a year earlier.
All 2 revenue readings, with sources
| As of | Revenue | Source |
|---|---|---|
| Dec 2024 | $20.5M | SEC filing |
| Dec 2025 | $31.9M | SEC filing |
Generate Biomedicines funding rounds & investors
Generate Biomedicines has raised $370M in one round: a Series C in November 2024.
Rounds before the IPO
| Date | Round | Raised | Valuation |
|---|---|---|---|
| Nov 2024 | Series C | $370M | $2B |
| Total raised | $370M |
Generate Biomedicines CEO, founders & employees
Michael Nally founded Generate Biomedicines in 2018 and runs it as CEO. Generate Biomedicines has 317 employees (November 2025, LinkedIn).
- Michael NallyCEO/Founder
Generate Biomedicines FAQ
What is Generate Biomedicines' revenue?
Generate Biomedicines' annual revenue was $31.9M in December 2025, according to an SEC filing.
Is Generate Biomedicines publicly traded?
Yes. Generate Biomedicines is a public company.
How much funding has Generate Biomedicines raised?
Generate Biomedicines raised $370M in one funding round: a Series C in November 2024.
How many employees does Generate Biomedicines have?
Generate Biomedicines has 317 employees as of November 2025, according to LinkedIn.
Who is the CEO of Generate Biomedicines?
Michael Nally is the CEO of Generate Biomedicines and founded the company in 2018.
Who founded Generate Biomedicines?
Michael Nally founded Generate Biomedicines in 2018.
Browse Data Science and Machine Learning Platforms
How this page is sourced
3 from public sources. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Nov 16, 2026Data disclaimerReport a correctionClaim this profileRun Generate Biomedicines? Join the podcast